Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02724891 · ClinicalTrials.gov registry record

Web-based Validation Pelvic Floor Questionnaires

A clinical trial of Pelvic Floor Dysfunction, sponsored by Columbia University.

Completed
Registry status
90
Enrollment target
5
Study locations

NCT02724891: Completed study of Pelvic Floor Dysfunction, sponsored by Columbia University.

NCT02724891 is a study of Pelvic Floor Dysfunction that has completed, run by Columbia University. The registered enrollment target is 90 participants. The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02724891, a study of Pelvic Floor Dysfunction, has completed, sponsored by Columbia University.

COMPLETED
Registry status
90 participants
Enrollment target
5
Study locations

Study Summary

Patient-reported outcomes are commonly used in healthcare. Examples include validated symptom-based questionnaires and health diaries. In the field of Female Pelvic Medicine and Reconstructive Surgery there are many questionnaires and diaries that have been validated for a paper-based administration. As technology is incorporated into delivery of medical care and research, investigators need to consider how to collect data electronically while ensuring that this new format is equivalent to the paper questionnaires they rely on. In this study, the investigators aim to validate a series of validated questionnaires and symptom diaries administered via the web and smartphone for a more streamlined care for the patients.

Primary Outcome

Subjects will complete the paper and either web-based or smartphone versions of the PFDI-20 with at least a 2 week interval between administration of the 2 versions.

Conditions Studied

Interventions

  • OTHER paper form
  • OTHER web/smartphone form

Study Locations (5)

Arkansas

  • University of Arkansas - Fayetteville

New York

  • Columbia University Irving Medical Center - New York

Texas

  • Houston Methodist Hospital - Houston

Wisconsin

  • University of Wisconsin School of Medicine and Public Health - Madison

Alberta

  • University of Calgary - Calgary

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2015-02
Est. Completion 2018-10
Columbia University

958 total trials

What the finished NCT02724891 record still lists

NCT02724891 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.

The record links to 1 condition, with Pelvic Floor Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which paper form is the first listed.

NCT02724891 lists 5 locations in 5 states (Arkansas, New York, Texas).

Frequently Asked Questions

What is clinical trial NCT02724891 about?

NCT02724891 is a clinical study titled "Web-based Validation Pelvic Floor Questionnaires". Patient-reported outcomes are commonly used in healthcare. Examples include validated symptom-based questionnaires and health diaries. In the field of Female Pelvic Medicine and Reconstructive Surgery there are many questionnaires and diaries that have been validated for a paper-based administration...

What is the current status of trial NCT02724891?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2015-02. Estimated completion is 2018-10.

What conditions does trial NCT02724891 study?

This clinical trial studies the following conditions: Pelvic Floor Dysfunction.

What interventions are being tested in trial NCT02724891?

The interventions under investigation include: paper form (OTHER), web/smartphone form (OTHER).

Who is sponsoring clinical trial NCT02724891?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02724891 being conducted?

This trial has 5 study locations across Arkansas, New York, Texas, Wisconsin, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Floor Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02724891, the US trial registry maintained by the National Library of Medicine. NCT02724891 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.